Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.
about
Structure and coding content of CST (BART) family RNAs of Epstein-Barr virusAn Epstein-Barr virus protein interacts with NotchEpstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchICEpstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replicationEpstein-Barr virus microRNAs are evolutionarily conserved and differentially expressedExpression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells.Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeatsEpstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2AEpstein-Barr virus-encoded RK-BARF0 protein expression.Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakiaThe Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.EBV latency types adopt alternative chromatin conformations.Human tumor virus utilizes exosomes for intercellular communication.EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth.Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses.Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines.Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.Structural analyses of the Epstein-Barr virus BamHI A transcriptsThe Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat.Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.The role of miRNAs and EBV BARTs in NPC.The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim.Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expressionTranscriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsHost-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programsAlterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas.An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitroEpstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.Alterations of the p53 gene in nasopharyngeal carcinoma.The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo.Epstein-Barr virus infection in carcinoma of the salivary gland
P2860
Q24524755-C3B59661-2A6A-453B-A694-3A352CFE2BE5Q24529019-672AAC80-2877-440B-8F15-1B2EB83B88C8Q24530175-D5C4369C-BE31-436F-B818-71CEC94BF41EQ24671870-2A32BFAC-CD66-4CA1-8878-A3927D5CC314Q25257225-04D3AC83-EFFB-4485-909E-BC0DC238E7A5Q30984201-94275B41-9989-4062-84A5-BAE92D18C30AQ33649035-98C3374A-7FB8-464E-8E75-04BF57A0FC34Q33794029-8F109630-F14B-4970-AE53-B6A345EB99BEQ33821864-1DF3F25E-680C-4B4A-BD2C-5412F8ADE2B6Q33891606-81DEB997-9C20-4EB9-A099-321E4BED2897Q33936163-A2AE0FD8-A5D3-4981-BFB7-9BE64B876966Q33987454-618EA3A9-3F29-48C8-AEB9-C802369A5C14Q34377767-8BDDF0D1-0F45-4A1E-9B53-D88C8EBADBFCQ34465612-09E3DF62-E6F5-4282-A007-0E8BFEB3CF96Q34485302-8AC159A9-32A6-478B-9F51-8393B6EEC3D9Q34547697-61188204-72BC-4F48-B801-71D7DCE1AA34Q34658852-255D5F53-D4E8-4008-A674-E8EE5194451DQ34703035-277C850D-A57C-4448-BA84-123076221F7FQ35171856-13D52E10-4EEA-44DE-A619-A0A45B1CCB3AQ35798133-5E3804D6-88F9-4C12-80E3-F2F60F5C52FDQ35832657-82BF114F-CF2E-4ED6-9B6A-393BFDE9D212Q35841701-2075BDEE-BA72-4621-AA3F-116848CBFA87Q35842451-DED9CDAF-D6C1-4F94-8741-9F1425C82C08Q35873657-1A7DCF67-4DA4-44CA-B7CC-41D6DDC12652Q35875444-9C4B7F1E-51EE-4310-8D42-1AC0261244B6Q35924359-FBCAF0B7-371A-4BDA-BA66-FB97D878ECDCQ35924384-96CC0CB1-66C8-4545-AD36-FC0A11D73CD9Q36066487-F6928D13-3FB0-4758-80EE-A8A1FDF69361Q36135900-F9D4CCFF-A872-4312-B76D-ABBBE0D5C105Q36564877-7B3E8B07-F846-4CA4-A8AD-F122501C1079Q36628203-C3C5A5AF-CCF1-4250-9863-533B65A2E32EQ36628631-EAE0144E-AC1A-4675-80E2-57E8FFC4AF5CQ36637195-A82A839F-D603-4A67-9DB6-BC731CD69CDDQ36653989-76776CD8-6549-40CE-A3E7-E84021EFD6DDQ36696963-0610F255-C5F7-4E40-8800-688A96B66F3EQ36697762-F990ED29-5A21-4216-B851-5477DED0B5C4Q36698270-ADA7AF0B-5568-4BB5-A219-12E7DF75989EQ36699468-FADB3EC6-F687-488D-BEA3-56CF16EA6A7EQ36822172-6A96FCBA-BD7E-4A21-BDB2-852C0763AEEAQ36829106-3074DA28-E085-4CC6-B5BF-B22DC1696B8D
P2860
Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.
description
1990 nî lūn-bûn
@nan
1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Novel transcription from the E ...... in a nasopharyngeal carcinoma.
@ast
Novel transcription from the E ...... in a nasopharyngeal carcinoma.
@en
type
label
Novel transcription from the E ...... in a nasopharyngeal carcinoma.
@ast
Novel transcription from the E ...... in a nasopharyngeal carcinoma.
@en
prefLabel
Novel transcription from the E ...... in a nasopharyngeal carcinoma.
@ast
Novel transcription from the E ...... in a nasopharyngeal carcinoma.
@en
P2093
P2860
P1433
P1476
Novel transcription from the E ...... in a nasopharyngeal carcinoma.
@en
P2093
A Rickinson
K Gilligan
N Raab-Traub
P Rajadurai
P2860
P304
P407
P50
P577
1990-10-01T00:00:00Z